# ALNYLAM PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:f95bc419-f349-4b0d-896d-2572577699d0 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 33 | | Claims under review | 2 | | Evidence records | 13 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:45:23.017038+00:00 | | Last reviewed | 2026-10-17T04:45:23.017038+00:00 | ## Identity - Legal name: ALNYLAM PHARMACEUTICALS, INC. - Display name: ALNYLAM PHARMACEUTICALS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T06:07:52.23787+00:00 | | Completeness | 0.455 | | Record Quality | 0.8 | | Directors | 10 | | Committees | 3 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | PUBLISHED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Amy W. Schulman: Director. Status: current. Independent: true. Since: 2014-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:7 - Colleen F. Reitan: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (member). claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:8 - David E.I. Pyott: Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:9 - Dennis A. Ausiello: Director. Status: current. Independent: true. Since: 2012-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:10 - Elliott Sigal: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:11 - Marc D. Hamburg: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:12 - Olivier Brandicourt: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member). claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:13 - Peter N. Kellogg: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:14 - Stuart A. Arbuckle: Director. Status: current. Independent: true. Since: 2026-01-01. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:15 - Yvonne L. Greenstreet: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:16 ## Committees - Audit (audit). Chair: Peter N. Kellogg. Members: Peter N. Kellogg (chair, current); Colleen F. Reitan (member, current); Olivier Brandicourt (member, current). committee_id=alpha:committee:alnylam-pharmaceuticals-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Peter N. Kellogg (member, current). committee_id=alpha:committee:alnylam-pharmaceuticals-inc:audit-chair - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Amy W. Schulman (member, current); Dennis A. Ausiello (member, current); Marc D. Hamburg (member, current). committee_id=alpha:committee:alnylam-pharmaceuticals-inc:nominating-and-governance ## Executive leadership - Bryan Andrew Supran: Chief Legal Officer [GC]. Status: unknown. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:17 - Christine Regan Akinc: Chief Corporate Communications Officer. Status: unknown. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:18 - Jeffrey V. Poulton: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:19 - Kevin Joseph Fitzgerald: Executive Vice President, Chief Scientific Officer and Head of Early Research & Early Development. Status: unknown. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:20 - Piyush Sharma: Chief Ethics & Compliance Officer. Status: unknown. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:21 - Pushkal Garg: EVice President of Development & Medical Affairs and Chief Research & Dev. Officer. Status: unknown. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:22 - Timothy J. Maines: Chief Technical Operations & Quality Officer. Status: unknown. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:23 - Tolga Tanguler: Executive VP & Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:24 - Yvonne L. Greenstreet: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:25 ## Governance events - DIRECTOR_APPOINTED: Stuart A. Arbuckle seat on ALNYLAM PHARMACEUTICALS, INC., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:vq21741eb47mo - DIRECTOR_APPOINTED: Peter N. Kellogg seat on ALNYLAM PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:vx3xbck7c5es - COMMITTEE_CREATED: Audit · Chair committee of ALNYLAM PHARMACEUTICALS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:qbc4oqerybf4 - COMMITTEE_MEMBER_ADDED: Peter N. Kellogg member of Audit · Chair, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1ecyn3m11m84ps - DIRECTOR_APPOINTED: Elliott Sigal seat on ALNYLAM PHARMACEUTICALS, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:lg5ioy14uutcs - DIRECTOR_APPOINTED: Yvonne L. Greenstreet seat on ALNYLAM PHARMACEUTICALS, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1os05wk6d3ack - DIRECTOR_APPOINTED: Olivier Brandicourt seat on ALNYLAM PHARMACEUTICALS, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:lqcz2mrfo2jg - DIRECTOR_APPOINTED: Marc D. Hamburg seat on ALNYLAM PHARMACEUTICALS, INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1tjj8t57chlun - DIRECTOR_APPOINTED: Colleen F. Reitan seat on ALNYLAM PHARMACEUTICALS, INC., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:njparlauc93d - COMMITTEE_MEMBER_ADDED: Colleen F. Reitan member of Audit, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:y3rjm2nd1eu - DIRECTOR_APPOINTED: David E.I. Pyott seat on ALNYLAM PHARMACEUTICALS, INC., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1vb8fhxxrlfd1 - DIRECTOR_APPOINTED: Amy W. Schulman seat on ALNYLAM PHARMACEUTICALS, INC., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:1j6r3zk15efclq - COMMITTEE_MEMBER_ADDED: Amy W. Schulman member of Nominating and Governance, effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:16cq70ldeac8v - DIRECTOR_APPOINTED: Dennis A. Ausiello seat on ALNYLAM PHARMACEUTICALS, INC., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-17T04:45:23.017038+00:00. event_id=alpha:event:transition:sdukie1yk94jm ## Scoped resources - `alpha://company/alnylam-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record - `alpha://company/alnylam-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/alnylam-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/alnylam-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=board - `alpha://company/alnylam-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/alnylam-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/alnylam-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/alnylam-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/alnylam-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/alnylam-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/alnylam-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/alnylam-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/alnylam-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/alnylam-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/alnylam-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/alnylam-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/alnylam-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/alnylam-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/alnylam-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/alnylam-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=events - `alpha://company/alnylam-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/alnylam-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/alnylam-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:peter-n-kellogg","name":"Peter N. Kellogg"},"source_id":"board_seats"}` - Claim alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:colleen-f-reitan","name":"Colleen F. Reitan"},"source_id":"board_seats"}` - Claim alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:olivier-brandicourt","name":"Olivier Brandicourt"},"source_id":"board_seats"}` - Claim alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:amy-w-schulman","name":"Amy W. Schulman"},"source_id":"board_seats"}` - Claim alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:32: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:dennis-a-ausiello","name":"Dennis A. Ausiello"},"source_id":"board_seats"}` - Claim alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:margaret-a-hamburg","name":"Marc D. Hamburg"},"source_id":"board_seats"}` ## Leadership - Amy W. Schulman: Director, Nominating and Governance. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:7. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd. - Colleen F. Reitan: Director, Audit. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:8. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd. - David E.I. Pyott: Director. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:9. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd. - Dennis A. Ausiello: Director, Nominating and Governance. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:10. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd. - Elliott Sigal: Director. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:11. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd. - Marc D. Hamburg: Director, Nominating and Governance. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:12. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd. - Olivier Brandicourt: Director, Audit. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:13. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd. - Peter N. Kellogg: Director, Audit · Chair. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:14. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd. - Stuart A. Arbuckle: Director. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:15. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd. - Yvonne L. Greenstreet: Director. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:16. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd. - Bryan Andrew Supran: Chief Legal Officer. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:caaf2601cc94e41d604b00d102bdb4955d1f666697dc325cf759db3ac6d2178c. - Christine Regan Akinc: Chief Corporate Communications Officer. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4a4e631eca73e2ce2765745a3baca4787a506dcf59398595f2d4ed3f04b10b6b. - Jeffrey V. Poulton: Chief Financial Officer. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66929166e6a0f476fa587e7e2e418d1171773a0ba289c729b155db0899cdc9a2. - Kevin Joseph Fitzgerald: Executive Vice President, Chief Scientific Officer and Head of Early Research & Early Development. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:615c91c4ec505909807969892579fd26190b40e7c4717785da41bc5ff43ffac1. - Piyush Sharma: Chief Ethics & Compliance Officer. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c5dd922b446b80300976434eca65da81c1a2ebfb8cbbde856dc753ec0148df1c. - Pushkal Garg: EVice President of Development & Medical Affairs and Chief Research & Dev. Officer. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:27efd1c9a3109e32fa28343cd155f40967f04a8c0754bd215bd8400893b41dd4. - Timothy J. Maines: Chief Technical Operations & Quality Officer. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66e740ddd0a350cff007fa41446902f9d16474055dc6e089204a1f51764d2287. - Tolga Tanguler: Executive VP & Chief Commercial Officer. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7cf0fa28fdb6e14f9fcdb07d26475348a6326ef19fe262cc43cf41d55f8b787a. - Yvonne L. Greenstreet: President and Chief Executive Officer. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d35b231f7ff1a9f9a75e6507d2fd2606ab46249006484d5b19e13b51db4563e0. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Peter N. Kellogg; Members Peter N. Kellogg (Chair); Colleen F. Reitan; Olivier Brandicourt. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_record:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8. - Nominating and Governance: Chair not stated; Members Amy W. Schulman; Dennis A. Ausiello; Marc D. Hamburg. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_record:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - Nasdaq-100 (NDX). Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:index_membership:34. Valid from: 2026-09-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:24e3e0a1948ea10a66303a2e7032cc9bbc5c4edf5c6d4eb77b262a15ea2009a5. ## Legal Name - ALNYLAM PHARMACEUTICALS, INC.. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d3938d89f12c94c9bdc237c1287d01f0a690f6335cc578739e079373fcbe3bce. ## Entity Status - Public listing published. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d3938d89f12c94c9bdc237c1287d01f0a690f6335cc578739e079373fcbe3bce. ## Published Fact - US. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d3938d89f12c94c9bdc237c1287d01f0a690f6335cc578739e079373fcbe3bce. - Healthcare. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d3938d89f12c94c9bdc237c1287d01f0a690f6335cc578739e079373fcbe3bce. ## Committee Appointment - Peter N. Kellogg: chair, Audit. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8. - Colleen F. Reitan: member, Audit. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8. - Olivier Brandicourt: member, Audit. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8. - Amy W. Schulman: member, Nominating and Governance. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8. - Dennis A. Ausiello: member, Nominating and Governance. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8. - Marc D. Hamburg: member, Nominating and Governance. Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8. ## Security Listing - ALNY (NASDAQ). Claim: alpha:claim:company:f95bc419-f349-4b0d-896d-2572577699d0:security_listing:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d3938d89f12c94c9bdc237c1287d01f0a690f6335cc578739e079373fcbe3bce. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:d3938d89f12c94c9bdc237c1287d01f0a690f6335cc578739e079373fcbe3bce: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc). - alpha:projection-evidence:document:7a71310a5f06fcc54110ecee3706ed18f0dacca342c3541f614d391dd6766dcd: [Alnylam Pharmaceuticals DEF 14A 2026-04-06](https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm). - alpha:projection-evidence:document:caaf2601cc94e41d604b00d102bdb4955d1f666697dc325cf759db3ac6d2178c: [Alnylam Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ALNY). - alpha:projection-evidence:document:4a4e631eca73e2ce2765745a3baca4787a506dcf59398595f2d4ed3f04b10b6b: [Alnylam Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ALNY). - alpha:projection-evidence:document:66929166e6a0f476fa587e7e2e418d1171773a0ba289c729b155db0899cdc9a2: ALNY executive roster source. - alpha:projection-evidence:document:615c91c4ec505909807969892579fd26190b40e7c4717785da41bc5ff43ffac1: [Alnylam Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ALNY). - alpha:projection-evidence:document:c5dd922b446b80300976434eca65da81c1a2ebfb8cbbde856dc753ec0148df1c: [Alnylam Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ALNY). - alpha:projection-evidence:document:27efd1c9a3109e32fa28343cd155f40967f04a8c0754bd215bd8400893b41dd4: [Alnylam Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ALNY). - alpha:projection-evidence:document:66e740ddd0a350cff007fa41446902f9d16474055dc6e089204a1f51764d2287: [Alnylam Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ALNY). - alpha:projection-evidence:document:7cf0fa28fdb6e14f9fcdb07d26475348a6326ef19fe262cc43cf41d55f8b787a: [Alnylam Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=ALNY). - alpha:projection-evidence:document:d35b231f7ff1a9f9a75e6507d2fd2606ab46249006484d5b19e13b51db4563e0: ALNY executive roster source. - alpha:projection-evidence:9ba1004d067de3d8e8ee090fc3af01300f3a277f7267ddfe2b5b1800b9366fa8: [Audit](https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm). - alpha:projection-evidence:24e3e0a1948ea10a66303a2e7032cc9bbc5c4edf5c6d4eb77b262a15ea2009a5: [Nasdaq-100](https://api.nasdaq.com/api/quote/list-type/nasdaq100). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/alnylam-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/alnylam-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/alnylam-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T06:07:51.856534+00:00; recorded 2026-10-17T06:07:51.856534+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.